J Korean Diabetes Assoc.  2007 Mar;31(2):175-179. 10.4093/jkda.2007.31.2.175.

A Typical Case of Fulminant Type 1 Diabetes Mellitus

• Lee JH
• Koh GP
• Yang JK
• Kim KH
• Im DM
• Park KY

• KMID: 2008087
• DOI: http://doi.org/10.4093/jkda.2007.31.2.175

Abstract

Recently type 1 diabetes with acute onset and no evidence of islet autoantibodies have been showed as "fulminant type 1 diabetes" and as novel subtype of type 1B diabetes. The study was made progress in Japan. We report a typical case of fulminant type 1 diabetes. A 24 years old male to be in good condition visited our hospital because of flu-like symptom, diarrhea, and abdominal discomfort. He has no medical history and family history of diabetes. The level of plasma glucose is 962 mg/dL, serum ketone body 5.8 mmol/L, arterial blood pH 7.111 and he was diagnosed as diabetic ketoacidosis. Anti-GAD antibody and islet cell antibody were negative and HbA1c is 5.5%. All of them were compatible with the diagnostic criteria of fulminant type 1 diabetes. After the patient has been treated with insulin, his symptoms were improved and abnormal laboratory data were normalized. We report this case with a review of the literature.

MeSH Terms

Autoantibodies
Blood Glucose
Diabetes Mellitus, Type 1*
Diabetic Ketoacidosis
Diarrhea
Humans
Hydrogen-Ion Concentration
Insulin
Islets of Langerhans
Japan
Male
Young Adult
Autoantibodies
Insulin

Reference

1. Bottazzo Gf, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet. 1974. 30:1279–1283.

2. Eisenbarth GS. Type 1 diabetes mellitus: a chronic autoimmune disease. N Engl J Med. 1986. 314:1360–1368.

3. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003. 26:Suppl 1. S5–S20.

4. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med. 2000. 342:301–307.

5. Imagawa A, Hanafusa T, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Toyoda T, Maruyama T, Makino H. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care. 2003. 26:2345–2352.

6. Tanaka S, Endo T, Aida K, Shimada H, Yokomori N, Kaneshige M, Furuya F, Amemiya D, Mochizuki M, Nakanishi K, Kobayashi T. Distinct diagnostic criteria of fulminant type 1 diabetes based on serum C-peptide response and HbA1c levels at onset. Diabetes Care. 2004. 27:1936–1941.

9. Nakanichi K, Kobayashi T, Sugimoto T, Itoh T, Murase T, Kosaka K. Dose pan-pancreatic involvement occur in IDDM? Diabetes Care. 1988. 11:100–101.

10. Kobayashi T. Immunology and immunogenetics of type I diabetes in Japan. IDF Bull. 1990. 35:34–37.

11. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence. Ann Med. 2000. 32:539–543.

12. Tanaka S, Kobayashi T, Momotsu T. A novel subtype of type 1 diabetes mellitus. N Engl J Med. 2000. 342:1835–1837.

13. Shimada A, Morinoto J, Kodama K, Oikawa Y, Irie J, Nakagawa Y, Narumi S, Saruta T. T-cell mediated autoimmunity may be involveed in fulminant type 1 diabetes. Diabetes care. 2002. 25:635–636.

14. Shimada A, Oikawa Y, Shigihara T, Senda T, Kodama K. A case of fulminant type 1 diabetes with strong evidence of autoimmunity (Letter). Diabetes Care. 2002. 25:1482–1483.

15. Miura Y, Suzuki A, Sato I, Kato Y, Oiso Y. A case of fulminant type 1 diabetes with graves' disease. Diabetes Care. 2002. 25:1894–1895.

16. Sakaue S, Nagata M, Wakabayashi O, Honda T, Yoshimura H, Yamaguchi E, Nishimura M. A case of fulminant type 1 diabetes with elevated rheumatoid factor and the temporal presence of thyroid stimulating hormone receptor antibody. Diabetes Care. 2002. 25:935–936.

17. Korani R, Nagata M, Imagawa A, Moriyama H, Yasuda K, Miyagawa J, Hanafusa T, Yokono K. T lymphocyte response against pancreatic beta cell antigens in fulminant type 1 diabetes. Diabetologia. 2004. 47:1285–1291.

18. Sekine N, Motokura T, Oki T, Umeda Y, Sasaki N, Hayashi M, Sato H, Fujita T, Kaneko T, Asano Y, Kikuchi K. Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome. JAMA. 2001. 285:1153–1154.

19. Nagaoka T, Terada M, Miyakoshi H. Insulin-dependent diabetes mellitus following acute pancreatitis caused by herpes simplex virus: a case report. Journal of the Japan Diabetes Society. 2001. 44:335–340.

20. Imagawa A, Hanafusa T, Makino H, Miyagawa J, Juto P. High tites of IgA antibodies to enterovirus in fulminant type-1 diabetes. Diabetologia. 2005. 48(2):290–293.

21. Imagawa A, Hanafusa T, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Maruyama T, Makino H. Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia. 2005. 48(2):294–300.

22. Jung TS, Chung SI, Kim MA, Kim SJ, Park MH, Kim DR, Kang MY, Hahm JR. A Korean Patient With Fulminant Autoantibody-Negative Type 1 Diabetes (Letter). Diabetes Care. 2004. 27:3023–3024.

23. Lernmark A. Rapid-onset type 1 diabetes with pancreatic exocrine dysfunction. N Engl J Med. 2000. 342:344–345.